Such loss of interest in sex is medically identified as hypoactive sexual desire disorder (HSDD).
There are some popular products that have either been designed or tested to treat HSDD.
Although the product is only approved to treat estrogen-resistant hot flashes, it has been used "off-label" by doctors and patients.
Off-label use means physicians prescribe drugs for a purpose other than what they are approved for.
Earlier this year, the company announced it was ending research of Viagra in women.